Brevibacterium
Brevibacterium is a genus of Gram-positive bacteria that are known for their role in the production of certain types of cheese and their presence on human skin. These bacteria are part of the family Brevibacteriaceae and are characterized by their rod-shaped morphology and ability to produce a distinctive odor.
Morphology and Characteristics[edit]
Brevibacterium species are rod-shaped and Gram-positive, meaning they retain the crystal violet stain used in the Gram staining procedure. They are non-motile and do not form spores. The cells are typically arranged in pairs or short chains. Brevibacterium species are aerobic, requiring oxygen for growth, and they exhibit a high G+C content in their DNA.
Habitat[edit]
Brevibacterium species are commonly found in soil, water, and on human skin. They are particularly known for their presence on the human foot, where they contribute to the characteristic odor. This odor is due to the production of sulfur-containing compounds, such as methanethiol, during the breakdown of amino acids.
Role in Cheese Production[edit]
One of the most well-known species, Brevibacterium linens, is used in the production of smear-ripened cheeses such as Limburger cheese, Munster cheese, and Tilsit cheese. These bacteria are responsible for the development of the cheese's rind and contribute to its flavor and aroma. The bacteria grow on the surface of the cheese, where they metabolize lactic acid and produce compounds that give the cheese its distinctive smell and taste.
Medical Relevance[edit]
While Brevibacterium species are generally considered non-pathogenic, they have been occasionally associated with opportunistic infections in humans, particularly in immunocompromised individuals. Such infections can include bacteremia, endocarditis, and osteomyelitis. However, these occurrences are rare, and Brevibacterium is not typically considered a major human pathogen.
Biochemical Properties[edit]
Brevibacterium species are known for their ability to degrade a wide range of organic compounds. They can utilize various carbon sources, including amino acids, carbohydrates, and lipids. The bacteria produce several enzymes, such as proteases, lipases, and deaminases, which contribute to their metabolic versatility.
Industrial Applications[edit]
Beyond cheese production, Brevibacterium species have potential applications in biotechnology and industry. Their enzymatic capabilities make them candidates for use in the degradation of environmental pollutants and the production of bioactive compounds. Research is ongoing to explore these possibilities further.
Taxonomy[edit]
The genus Brevibacterium is part of the order Micrococcales and the class Actinomycetia. It is closely related to other genera within the family Brevibacteriaceae. The taxonomy of Brevibacterium is based on genetic and phenotypic characteristics, and new species continue to be described as more isolates are studied.
Conclusion[edit]
Brevibacterium is a diverse genus of bacteria with significant roles in both natural and industrial processes. While best known for their contribution to cheese production, these bacteria also have potential applications in biotechnology and environmental science. Understanding their biology and ecology is important for harnessing their capabilities in various fields.
| Microbiology: Bacteria | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian